BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26813970)

  • 1. Serum Glycans as Risk Markers for Non-Small Cell Lung Cancer.
    Ruhaak LR; Stroble C; Dai J; Barnett M; Taguchi A; Goodman GE; Miyamoto S; Gandara D; Feng Z; Lebrilla CB; Hanash S
    Cancer Prev Res (Phila); 2016 Apr; 9(4):317-23. PubMed ID: 26813970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diacetylspermine Is a Novel Prediagnostic Serum Biomarker for Non-Small-Cell Lung Cancer and Has Additive Performance With Pro-Surfactant Protein B.
    Wikoff WR; Hanash S; DeFelice B; Miyamoto S; Barnett M; Zhao Y; Goodman G; Feng Z; Gandara D; Fiehn O; Taguchi A
    J Clin Oncol; 2015 Nov; 33(33):3880-6. PubMed ID: 26282655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-surfactant protein B as a biomarker for lung cancer prediction.
    Sin DD; Tammemagi CM; Lam S; Barnett MJ; Duan X; Tam A; Auman H; Feng Z; Goodman GE; Hanash S; Taguchi A
    J Clin Oncol; 2013 Dec; 31(36):4536-43. PubMed ID: 24248694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene polymorphisms of SFTPB rs7316, rs9752 and PAOX rs1046175 affect the diagnostic value of plasma Pro-SFTPB and DAS in Chinese Han non-small-cell lung cancer patients.
    Wang K; Huang Q; Zhao G; Yang J; Yang K; Huang Y
    J Cell Biochem; 2019 Sep; 120(9):14804-14812. PubMed ID: 31016788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental study of peripheral-blood pro-surfactant protein B for screening non-small cell lung cancer.
    He Y; Jiang Z; Tong F; Li M; Yin X; Hu S; Wang L
    Acta Cir Bras; 2017 Jul; 32(7):568-575. PubMed ID: 28793041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Lung Cancer Risk on the Basis of a Biomarker Panel of Circulating Proteins.
    ; Guida F; Sun N; Bantis LE; Muller DC; Li P; Taguchi A; Dhillon D; Kundnani DL; Patel NJ; Yan Q; Byrnes G; Moons KGM; Tjønneland A; Panico S; Agnoli C; Vineis P; Palli D; Bueno-de-Mesquita B; Peeters PH; Agudo A; Huerta JM; Dorronsoro M; Barranco MR; Ardanaz E; Travis RC; Byrne KS; Boeing H; Steffen A; Kaaks R; Hüsing A; Trichopoulou A; Lagiou P; La Vecchia C; Severi G; Boutron-Ruault MC; Sandanger TM; Weiderpass E; Nøst TH; Tsilidis K; Riboli E; Grankvist K; Johansson M; Goodman GE; Feng Z; Brennan P; Johansson M; Hanash SM
    JAMA Oncol; 2018 Oct; 4(10):e182078. PubMed ID: 30003238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating pro-surfactant protein B as a risk biomarker for lung cancer.
    Taguchi A; Hanash S; Rundle A; McKeague IW; Tang D; Darakjy S; Gaziano JM; Sesso HD; Perera F
    Cancer Epidemiol Biomarkers Prev; 2013 Oct; 22(10):1756-61. PubMed ID: 23897585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Lung Cancer: What Comes Next?
    Peled N; Ilouze M
    J Clin Oncol; 2015 Nov; 33(33):3847-8. PubMed ID: 26304887
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer.
    Shi GL; Chen Y; Sun Y; Yin YJ; Song CX
    Clin Lab; 2017 Jan; 63(1):133-140. PubMed ID: 28164492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma pro-surfactant protein B and lung function decline in smokers.
    Leung JM; Mayo J; Tan W; Tammemagi CM; Liu G; Peacock S; Shepherd FA; Goffin J; Goss G; Nicholas G; Tremblay A; Johnston M; Martel S; Laberge F; Bhatia R; Roberts H; Burrowes P; Manos D; Stewart L; Seely JM; Gingras M; Pasian S; Tsao MS; Lam S; Sin DD;
    Eur Respir J; 2015 Apr; 45(4):1037-45. PubMed ID: 25614175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.
    Yuan JM; Ross RK; Chu XD; Gao YT; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):767-73. PubMed ID: 11440962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
    Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
    Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Niu L; Song X; Wang N; Xue L; Song X; Xie L
    Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
    Hoagland LF; Campa MJ; Gottlin EB; Herndon JE; Patz EF
    Cancer; 2007 Nov; 110(10):2260-8. PubMed ID: 17918261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipidomic biomarkers for non-small cell lung cancer in nonsmoking female patients.
    Noreldeen HAA; Du L; Li W; Liu X; Wang Y; Xu G
    J Pharm Biomed Anal; 2020 Jun; 185():113220. PubMed ID: 32145537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling tumor-associated antibodies for early detection of non-small cell lung cancer.
    Zhong L; Coe SP; Stromberg AJ; Khattar NH; Jett JR; Hirschowitz EA
    J Thorac Oncol; 2006 Jul; 1(6):513-9. PubMed ID: 17409910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.